Key facts
- It has raised $810K; the latest was Early Stage VC ($810K) in Jul 2025.
- Notable investors include Development Bank of Wales, NLC Health Ventures, Utrecht Holdings, Orthopaedic Research UK.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Amotio
- ·The full record, as it builds
Funding rounds
No funding rounds for Amotio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amotio
Developer of a personalized technological approach intended for orthopedic revision surgery and bone cement removal. The company develops a patient-specific, precision-based procedure for bone cement removal in major joint revision surgery through digital joint mapping, templating and surgical planning, patent-specific intelligent surgical guide printing, and a precision-guided bone cement removal device, enabling patients to have better outcomes and quality of life, shorter surgical time and reduced cost burden to health care providers.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2022
- Website
- amotio.health/
- Ownership
- Privately Held (backing)
Amotio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amotio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amotio in its N-PORT filings yet. We sweep new filings monthly.